Goldman Sachs’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
4,715
-37,428
| -89% | -$1.82M | ﹤0.01% | 4659 |
|
|
2025
Q1 | $908K | Buy |
42,143
+28,273
| +204% | +$609K | ﹤0.01% | 3869 |
|
|
2024
Q4 | $373K | Buy |
+13,870
| New | +$373K | ﹤0.01% | 4442 |
|
|
2023
Q1 | – | Sell |
-3,355
| Closed | -$50.7K | – | 5126 |
|
|
2022
Q4 | $50.7K | Sell |
3,355
-265
| -7% | -$4.01K | ﹤0.01% | 4789 |
|
|
2022
Q3 | $45K | Sell |
3,620
-308
| -8% | -$3.83K | ﹤0.01% | 5046 |
|
|
2022
Q2 | $38K | Buy |
3,928
+164
| +4% | +$1.59K | ﹤0.01% | 5332 |
|
|
2022
Q1 | $63K | Sell |
3,764
-20
| -0.5% | -$335 | ﹤0.01% | 5418 |
|
|
2021
Q4 | $96K | Sell |
3,784
-1,711
| -31% | -$43.4K | ﹤0.01% | 5234 |
|
|
2021
Q3 | $246K | Sell |
5,495
-1,139
| -17% | -$51K | ﹤0.01% | 4766 |
|
|
2021
Q2 | $268K | Sell |
6,634
-1,339
| -17% | -$54.1K | ﹤0.01% | 4761 |
|
|
2021
Q1 | $425K | Buy |
7,973
+5,523
| +225% | +$294K | ﹤0.01% | 4462 |
|
|
2020
Q4 | $98K | Sell |
2,450
-7,241
| -75% | -$290K | ﹤0.01% | 4474 |
|
|
2020
Q3 | $553K | Buy |
9,691
+7,317
| +308% | +$418K | ﹤0.01% | 3621 |
|
|
2020
Q2 | $175K | Sell |
2,374
-639
| -21% | -$47.1K | ﹤0.01% | 4030 |
|
|
2020
Q1 | $149K | Buy |
3,013
+50
| +2% | +$2.47K | ﹤0.01% | 4040 |
|
|
2019
Q4 | $228K | Sell |
2,963
-914
| -24% | -$70.3K | ﹤0.01% | 3943 |
|
|
2019
Q3 | $155K | Buy |
3,877
+352
| +10% | +$14.1K | ﹤0.01% | 3978 |
|
|
2019
Q2 | $118K | Buy |
3,525
+30
| +0.9% | +$1K | ﹤0.01% | 3968 |
|
|
2019
Q1 | $185K | Sell |
3,495
-936
| -21% | -$49.5K | ﹤0.01% | 3909 |
|
|
2018
Q4 | $208K | Sell |
4,431
-833
| -16% | -$39.1K | ﹤0.01% | 3728 |
|
|
2018
Q3 | $463K | Buy |
5,264
+222
| +4% | +$19.5K | ﹤0.01% | 3481 |
|
|
2018
Q2 | $524K | Sell |
5,042
-67
| -1% | -$6.96K | ﹤0.01% | 3500 |
|
|
2018
Q1 | $409K | Buy |
+5,109
| New | +$409K | ﹤0.01% | 3571 |
|
|
2017
Q3 | – | Sell |
-4,332
| Closed | -$650K | – | 4283 |
|
|
2017
Q2 | $650K | Buy |
+4,332
| New | +$650K | ﹤0.01% | 3380 |
|
|
2016
Q3 | – | Sell |
-511
| Closed | -$105K | – | 4548 |
|
|
2016
Q2 | $105K | Sell |
511
-13,220
| -96% | -$2.72M | ﹤0.01% | 4108 |
|
|
2016
Q1 | $3.49M | Sell |
13,731
-13,559
| -50% | -$3.44M | ﹤0.01% | 2250 |
|
|
2015
Q4 | $9.37M | Buy |
27,290
+10,716
| +65% | +$3.68M | ﹤0.01% | 1718 |
|
|
2015
Q3 | $4.22M | Buy |
16,574
+218
| +1% | +$55.5K | ﹤0.01% | 2115 |
|
|
2015
Q2 | $4.59M | Buy |
+16,356
| New | +$4.59M | ﹤0.01% | 2122 |
|